Summary
method, described by Hodge et al. (3) in 1989. Transrectal ultrasound guided prostete biopsy (TRUS-BX) is accepted as a standard procedure in the diagnosis of prostate cancer. Having established that the prostate spesific antigen (PSA) could be a useful marker for detection of prostatic cancer there has been a significant increase in the number of biopsies (4). However most of patients undergoing TRUS-BX have discomfort and % 20 of these patients experienced severe pain about the procedure (3, 5) . Altough TRUS-BX is a standard common procedure there 500 mg of ciprofloxacin starting two days before and at least five days after the procedure. Bowel preparation was made with two fleet enema, one of them at previous night and the other one two hours before the procedure. After giving detailed information and obtaining consent form, the patients were taken to the table on the lateral decubit position. TRUS was performed using a 6.5-MHz transrectal probe. The prostate volume was calculated using both sagittal and transverse plans. Ten point linear visual analog scale (VAS) was used to determine the degree of the pain during transrectal ultrasound guided prostate biopsy. The pain arising from the probe input and manipulation (VAS-1) and the pain caused by the needle while taking biopsies from prostate (VAS-2) were assesed. All patients were observed for two hours for any complications such as rectal bleeding, hematuria, voiding difficulty and fever. Differences in the age, PSA levels, prostate volume, VAS scores were compared between two different anestethic practice groups. The comparisons about age, prostate volume and pain scores between two groups were applied using Mann-Whitney U test. Complication rates were examined with the Pearson chi-square test.
RESULTS
The mean ages were not statisticially different between two groups: 65.2 ± 8.3 for group 1, 66.1 ± 7.7 for group 2. Mean PSA levels, prostate volumes and complication rates were similar and there was no statistically differences between the groups (Table 1) . A critical status did not develop with respect to complications. The mean PSA levels were similar in group 1 (15.5 ± 23.1) and in group 2 (11.9 ± 13.6 ng/ml). The only statistically significant difference was determined in VAS-2 score between two groups. Mean pain score caused by the needle while taking biopsies from prostate (VAS-2) was lower in group 2 than in group 1. Mean VAS-2 scores were 4.54 ± 1.02 in group 1 and 2.06 ± 0.79 in group 2, respectively. There was no meaningful difference between the two groups of VAS-1 score which shows the pain about probe manipulation (Table 2) . is no certain protocol or guideline for the preparation of the patient and need for analgesia and the technique used for administration (3, 5) . There are many different approaches to reduce the pain and enhance the patients adaptation to the procedure. There is no concensus about which method to use but the patient' s consciousness, prior history about anorectal diseases, pain threshold of the patient, biopsy experience, socio-cultural level are important factors for the decision. The use of periprostatic nerve blockade (PPNB) had been introduced as early as 1996 (6) for minimizing prostatic biopsy pain with lignocaine local anaesthesia. Many studies evaluated and conclusively proved the benefit of PPNB (7-9). In this study, we evaulated the pain control in patients who have TRUS-BX for detection prostate cancer, using PPNB for anaesthesia. We compared the efficacy of periprostatic nerve blockage with intrarectal gel instillation and just perianal intrarectal gel instillation during TRUS-guided prostate biopsy.
MATERIALS AND METHODS
473 men who underwent ultrasound guided prostate biopsy from 2009 to 2012, were enrolled in this study. Increased prostate speific antigen (PSA), abnormal digital rectal examination findings and serum PSA levels higher than 2.5 ng/ml were the inclusion criterias. The patients were divided into two groups: in group 1 (159 patients) biopsies were performed after administering perianal intrarectal lidocain gel and in group 2 (314 patients) periprostatic nerve blockade was performed in addition to perianal intrarectal lidocain gel. Injections were delivered at the angle between the seminal vesicle and prostate on each side using 5 cc of 2% lidocain. Exclusion criterias are as follows: bleeding diathesis and/or use of anticoagulant; anorectal diseases such as hemorrhoids, anal fissures, anal surgery; acute prostatitis; pelvic pain syndrome; history of lidocaine allergies; inability to rate a visual analog scale (VAS). All patients receieved standard antibiotic prophylaxis with Table 2 .
The statistical data of VAS scores in the two groups. 
DISCUSSION
Ultrasound guided prostate biopsy is a standard method used to detect prostate cancer. Pain during TRUS-BX is an important problem that is associated with the patient tolerance about procedure (5, 10-12). Pain mainly depends on two factors: anal discomfort due to the probe insertion and manipulation of the probe and the insertion of the needle through prostate capsule. Periprostatic nerve blockage was firstly defined by Nash et al. in 1996 and it is a good choice to reduce the pain (6). In this study it was suggested to inject at the junction of the base of the prostate and seminal vesicles. These findings were similarly confirmed by Pareek et al. (9) . There are many studies demonstrating that periprostatic nerve blockade is better than plasebo (13-21).
Recently new methods are being tested in various studies. In a study with 430 patients, acetaminophen and EMLA cream with intravenous injection of tramadol were found safe, easy, and effective methods of controlling pain during the procedure (18). In some studies midazolam was considered to be a suitable anesthetic during prostate biopsy (17, 20, 21). The application of perianal intrarectal gel and cream provides a good pain relief caused by probe manipulation (14, 23, 24). In the other hand, there are some studies showing that lidocaine gel did not diminish the sensation of pain (16, 25, 26). Lidocaine suppositories are found an easyto-use and cheap method of local analgesia, with acceptable results (27). In a study published in 2011 by Skriapas et al., the use of topical lidocaine gel and glyceryl trinitrate ointment (GTN) as an adjunct to periprostatic anesthesia to reduce anal pain and discomfort due to probe insertion was found very effective and safe (28).
In the other study lidocaine spray was found to provide significantly better pain control than cream and anaesthetic gel (29). Furthermore there are some studies comparing different anesthetic substances for pain relief. In a study by Olmez et al., tramadol and lornoxicam were used for pain reduction and tramadol was found to be more effective (30). Hirsh et al. had similar findings about tramadol in their study (31). In our study, pain scores related to probe manipulation was similar between two groups but there was a very significant difference between the pain score caused by the needle used to take biopsy cores. It was shown that periprostatic nerve blockade is a very good choice for pain control and compliance of the patient to the procedure although it is not effective for anorectal discomfort caused by the probe. We recommend the use of perianal intrarectal lidocain gel and periprostatic nerve blockade combination in TRUS-guided prostate biopsises. This combination is effective, cheap, safe and easy to perform. 
